These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24627446)

  • 21. Exogenous 3-Iodothyronamine Rescues the Entorhinal Cortex from β-Amyloid Toxicity.
    Accorroni A; Rutigliano G; Sabatini M; Frascarelli S; Borsò M; Novelli E; Bandini L; Ghelardoni S; Saba A; Zucchi R; Origlia N
    Thyroid; 2020 Jan; 30(1):147-160. PubMed ID: 31709926
    [No Abstract]   [Full Text] [Related]  

  • 22. Exogenous 3-Iodothyronamine (T
    Bandini L; Sacripanti G; Borsò M; Tartaria M; Fogliaro MP; Giannini G; Carnicelli V; Figuccia ME; Verlotta S; De Antoni F; Zucchi R; Ghelardoni S
    Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-(3-Ethoxy-phenyl)-4-pyrrolidin-1-yl-3-trifluoromethyl-benzamide (EPPTB) prevents 3-iodothyronamine (T1AM)-induced neuroprotection against kainic acid toxicity.
    Landucci E; Gencarelli M; Mazzantini C; Laurino A; Pellegrini-Giampietro DE; Raimondi L
    Neurochem Int; 2019 Oct; 129():104460. PubMed ID: 31075293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fructose-induced hepatic gluconeogenesis: effect of L-carnitine.
    Rajasekar P; Anuradha CV
    Life Sci; 2007 Mar; 80(13):1176-83. PubMed ID: 17239403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of 3-iodothyronamine (3-T
    Li ZM; Miller M; Gachkar S; Mittag J; Schriever SC; Pfluger PT; Schramm KW; De Angelis M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1165():122553. PubMed ID: 33503577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression.
    Assadi-Porter FM; Reiland H; Sabatini M; Lorenzini L; Carnicelli V; Rogowski M; Selen Alpergin ES; Tonelli M; Ghelardoni S; Saba A; Zucchi R; Chiellini G
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells.
    Agretti P; De Marco G; Russo L; Saba A; Raffaelli A; Marchini M; Chiellini G; Grasso L; Pinchera A; Vitti P; Scanlan TS; Zucchi R; Tonacchera M
    J Mol Endocrinol; 2011 Aug; 47(1):23-32. PubMed ID: 21511808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function.
    Chiellini G; Frascarelli S; Ghelardoni S; Carnicelli V; Tobias SC; DeBarber A; Brogioni S; Ronca-Testoni S; Cerbai E; Grandy DK; Scanlan TS; Zucchi R
    FASEB J; 2007 May; 21(7):1597-608. PubMed ID: 17284482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3-Iodothyroacetic acid (TA
    Laurino A; Landucci E; Resta F; De Siena G; Matucci R; Masi A; Raimondi L
    Neurochem Int; 2018 May; 115():31-36. PubMed ID: 29032008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biosynthesis of 3-Iodothyronamine From T4 in Murine Intestinal Tissue.
    Hoefig CS; Wuensch T; Rijntjes E; Lehmphul I; Daniel H; Schweizer U; Mittag J; Köhrle J
    Endocrinology; 2015 Nov; 156(11):4356-64. PubMed ID: 26348473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3-Iodothyronamine-mediated metabolic suppression increases the phosphorylation of AMPK and induces fuel choice toward lipid mobilization.
    Ju H; Shin H; Son C; Park K; Choi I
    Horm Metab Res; 2015 Jul; 47(8):605-10. PubMed ID: 25372779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central effects of thyronamines on glucose metabolism in rats.
    Klieverik LP; Foppen E; Ackermans MT; Serlie MJ; Sauerwein HP; Scanlan TS; Grandy DK; Fliers E; Kalsbeek A
    J Endocrinol; 2009 Jun; 201(3):377-86. PubMed ID: 19273499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice.
    Manni ME; De Siena G; Saba A; Marchini M; Dicembrini I; Bigagli E; Cinci L; Lodovici M; Chiellini G; Zucchi R; Raimondi L
    Br J Pharmacol; 2012 May; 166(2):650-8. PubMed ID: 22225569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
    Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
    Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of scopolamine pretreatment on 3-iodothyronamine (T1AM) effects on memory and pain in mice.
    Laurino A; Lucenteforte E; De Siena G; Raimondi L
    Horm Behav; 2017 Aug; 94():93-96. PubMed ID: 28711308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A validated LC-MS/MS method for cellular thyroid hormone metabolism: Uptake and turnover of mono-iodinated thyroid hormone metabolites by PCCL3 thyrocytes.
    Richards KH; Schanze N; Monk R; Rijntjes E; Rathmann D; Köhrle J
    PLoS One; 2017; 12(8):e0183482. PubMed ID: 28837607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles.
    Vesterdal LK; Danielsen PH; Folkmann JK; Jespersen LF; Aguilar-Pelaez K; Roursgaard M; Loft S; Møller P
    Toxicol Appl Pharmacol; 2014 Jan; 274(2):350-60. PubMed ID: 24121055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hormonal regulation of ketone-body metabolism in man.
    Alberti KG; Johnston DG; Gill A; Barnes AJ; Orskov H
    Biochem Soc Symp; 1978; (43):163-82. PubMed ID: 749914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Iodothyronamine Affects Thermogenic Substrates' Mobilization in Brown Adipocytes.
    Gencarelli M; Laurino A; Landucci E; Buonvicino D; Mazzantini C; Chiellini G; Raimondi L
    Biology (Basel); 2020 May; 9(5):. PubMed ID: 32375297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation.
    Braulke LJ; Klingenspor M; DeBarber A; Tobias SC; Grandy DK; Scanlan TS; Heldmaier G
    J Comp Physiol B; 2008 Feb; 178(2):167-77. PubMed ID: 17912534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.